Clearmind Medicine Inc. entered an agreement to issue $2.7 million of convertible promissory notes at a 10% original issue discount for net proceeds of $2.43 million.
Key takeaways
The Company will issue $2,700,000 aggregate principal amount of convertible promissory notes to CLA Investors.
The notes are priced at 90% of principal, resulting in $2,430,000 in gross proceeds.
The transaction is expected to close on or about April 21, 2026.
This issuance is part of a previously announced $10 million securities purchase agreement dated September 17, 2025.